Results 151 to 160 of about 5,339,936 (244)

Artificial Intelligence Integration With Nanotechnology for Cancer Therapy

MedComm, Volume 7, Issue 9, September 2026.
AI‐enabled nanotechnology provides a continuous learning framework for cancer therapy by integrating nanomaterial design, biological interactions, tumor delivery, clinical data, and therapeutic feedback to support predictive design, patient‐aware optimization, and improved translational decision‐making.
Shengbin Liu, Zhi Liu, Haixing Shi, Chengyi Wei, Ruijie Zhang, Xiangrong Song   +5 more
wiley   +1 more source

Microenvironment crosstalk and immune evasion of circulating tumor cells: From mechanism to clinical significance

Chinese Medical Journal
. Circulating tumor cells (CTCs), shed from the primary malignancies, are regarded as the “seeds” of tumor metastasis. They employ sophisticated strategies to evade immune detection during blood circulation by engaging with various blood components ...
Shi Chen, Sirui Zhang, Ying Shi, Xiaowei Liu, Xiangxiang Pan   +4 more
doaj   +1 more source

Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancer. [PDF]

J Transl Med, 2023
Farhang Ghahremani M, Seto KKY, Cho W, Miller MC, Smith P, Englert DF.   +5 more
europepmc   +1 more source

Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications

, 2015
Stimulus responsive release of Circulating Tumor Cells (CTCs), with high recovery rates from their capture platform, is highly desirable for off-chip analyses.
Cote, Richard J, Schlegel, Richard, Agarwal, Ashutosh, Datar, Ram H, Parasido, Erika, Liu, Stephen, Albanese, Chris, Williams, Anthony, Rawal, Siddarth, Ao, Zheng   +9 more
core   +1 more source

Ursodeoxycholic Acid Reduces Angiotensin‐Converting Enzyme 2 Activity and Suppresses Cytokine Storm Syndrome in Patients With Coronavirus Disease 2019

MedComm, Volume 7, Issue 9, September 2026.
SARS‐CoV‐2 infection causes COVID‐19 and stimulates immune cells, such as dendritic cells, monocytes, and macrophages, to increase levels of many cytokines. Ursodeoxycholic acid (UDCA) inhibits farnesoid X receptor (FXR), resulting in a decrease in the activity of angiotensin‐converting enzyme 2 (ACE2), the main receptor on the membrane for SARS‐CoV‐2.
Zhaowei Tong, Jiawei Zhu, Jianfeng Zhong, Qi Wang, Fuchu Qian, Lili Zhao, Weihong Wang, Yuepao Cai, Kefeng Qin   +8 more
wiley   +1 more source

Distribution of circulating tumor cell phenotype in early cervical cancer

Cancer Management and Research, 2019
Li Pan, Gaoshu Yan, Wenli Chen, Lei Sun, Jichuan Wang, Jialin YangRadiotherapy Department, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, People’s Republic of ...
Pan L, Yan G, Chen W, Sun L, Wang J, Yang J   +5 more
doaj  

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact. [PDF]

Cancers (Basel), 2023
Vardas V, Tolios A, Christopoulou A, Georgoulias V, Xagara A, Koinis F, Kotsakis A, Kallergi G.   +7 more
europepmc   +1 more source

High‐Content CRISPR Screening: Methods and Applications

MedComm, Volume 7, Issue 9, September 2026.
High‐content CRISPR screening represents a paradigm shift in functional genomics, moving beyond traditional survival‐based readouts to enable multidimensional mapping of genotype–phenotype relationships. This review systematically outlines the methodological evolution of this approach, detailing advances in perturbation modalities, delivery systems ...
Yike Zhang, Yimeng Zhang, Xudong Tang, Xinyu Deng, Yitian Zhou, Yanfeng Wu, Jianhua Luo   +6 more
wiley   +1 more source

Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients. [PDF]

Dis Markers, 2022
Weng X, YangYang, Cai Y.
europepmc   +1 more source

The isolation and characterization of circulating tumor cells from head and neck cancer patient blood samples using spiral microfluidic technology

, 2019
Metastasis is responsible for 90% of cancer-related deaths. The study of circulating tumor cells (CTCs) enables the study of the units of disease responsible for the process of metastasis.
Chamindie Punyadeera, Warkiani, Majid Ebrahimi, Punyadeera, Chamindie, Majid Ebrahimi Warkiani, Kulasinghe, Arutha, Kulasinghe, A, Warkiani, ME, Arutha Kulasinghe, Punyadeera, C   +8 more
core   +1 more source